Abstract:Background: Traumatic brain injury (TBI) and spinal cord injury (SCI) are capable of causing severe sen-sory, motor and autonomic nervous system dysfunctions. However, effective treatments for TBI and SCI are still unavailable, mainly because the death of nerve cells is uncontrollable. Necroptosis is a type of programmed cell death and a critical mechanism in the process of neuronal cell death. However, the role of necroptosis has not been comprehensively defined in TBI and SCI.Aim of review: This review aimed to summarize the role of necroptosis in central nervous system (CNS) trauma and its therapeutic implications and present important suggestions for researchers conducting in-depth research.Key scientific concepts of review: Necroptosis is orchestrated by a complex comprising the receptor -interacting protein kinase (RIPK)1, RIPK3 and mixed lineage kinase domain-like protein (MLKL) proteins. Mechanistically, RIPK1 and RIPK3 form a necrosome with MLKL. After MLKL dissociates from the necro-some, it translocates to the plasma membrane to induce pore formation in the membrane and then induces necroptosis. In this review, the necroptosis signalling pathway and the execution of necroptosis are briefly discussed. In addition, we focus on the existing information on the mechanism by which necroptosis participates in CNS trauma, particularly in the temporal pattern of RIPKs and in different cell types. Furthermore, we describe the association of miRNAs and necroptosis and the relationship between different types of CNS trauma cell death. Finally, this study highlights agents likely capable of curtailing such a type of cell death according to results optimization and CNS trauma and presents important sug-gestions for researchers conducting in-depth research.(c) 2022 The Authors. Published by Elsevier B.V. on behalf of Cairo University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Necroptosis in Neuronal Injury and Neuroprotective Effects of Necrostatins

Inhibition of Receptor-Interacting Protein 3 Upregulation and Nuclear Translocation Involved in Necrostatin-1 Protection Against Hippocampal Neuronal Programmed Necrosis Induced by Ischemia/reperfusion Injury.

Necroptosis in Inflammatory Bowel Disease and Other Intestinal Diseases

Role of necroptosis in traumatic brain and spinal cord injuries

Mitochondrial Mechanisms of Necroptosis in Liver Diseases

A narrative review of the role of necroptosis in liver disease: a double-edged sword

Research progress in necroptosis

Necroptosis, a Novel Type of Programmed Cell Death, Contributes to Early Neural Cells Damage after Spinal Cord Injury in Adult Mice.

Molecular Insights into the Mechanism of Necroptosis: The Necrosome as a Potential Therapeutic Target

Necroptosis inhibitors: mechanisms of action and therapeutic potential

Crosstalk among mitophagy, pyroptosis, ferroptosis, and necroptosis in central nervous system injuries

The Role of Necroptosis in Cerebral Ischemic Stroke

Protein phosphorylation and kinases: Potential therapeutic targets in necroptosis

The Potential Role of Necroptosis in Clinical Diseases (Review)

Necrostatin-1: a promising compound for neurological disorders

The Role of Neutrophil NETosis in Organ Injury: Novel Inflammatory Cell Death Mechanisms

Necrosis Links Neurodegeneration and Neuroinflammation in Neurodegenerative Disease

Research trends, hot spots and prospects for necroptosis in the field of neuroscience

Crosstalk Between Cell Death and Spinal Cord Injury: Neurology and Therapy

Small-Molecule Inhibitors of Necroptosis: Current Status and Perspectives.

Regulated Necrosis in Glaucoma: Focus on Ferroptosis and Pyroptosis